An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)
Clinical trial NCT02831673 · COMPLETED
Trial details
- NCT number
- NCT02831673
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-21
- Primary completion
- 2018-03-29
- Enrollment
- 719
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.